George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,500 shares at $970.00 ($3.4M) on 2024-02-22, disclosed to the SEC on 2024-02-26.
Open-market sale of $3.4M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $960.00 | 1,000 | $960K | 28.3% |
| 2 | $965.00 | 1,000 | $965K | 28.5% |
| 3 | $970.00 | 1,000 | $970K | 28.6% |
| 4 | $985.00 | 500 | $493K | 14.5% |
| Total | $967.86 avg | 3,500 | $3.4M | 100% |
| Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |
| REGN | SELL | 2021-11-18 | $7.0M | — | Filing → |